Tag: life sciences
-

Precision Drug Trial Shows Solid Tumor Shrinkage
Partial results from a clinical trial show a drug to stop specific cancer-causing proteins shrinks advanced tumors in some patients across several tumor types.
-

Phone Video Algorithm Screens for Stroke
A medical informatics team designed a computer model from patient videos to help emergency room physicians quickly diagnose stroke.
-

Start-Up Developing Engineered B-Cell Therapies
A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from engineered B-cells in the immune system.
-

Roche Gains Covid-19 Oral Drug Candidate
Global drug maker Roche Group is acquiring an experimental antiviral therapy for Covid-19 infections taken as a oral drug, rather than an infusion.
-

Carb-X Funding Nanoscale Sponge to Treat Sepsis
A company developing tiny particles made of cellular material to soak-up toxins in the body received a $4 million award to advance its sepsis treatment.
-

Software Designed to Model, Visualize Brain Circuits
An academic-industry team designed a web-based software tool to ease the computer modeling, simulation, and visualization of the brain’s nerve cell circuits.
-

Covid-19 Vaccine Challenge Trial Underway
Researchers in the U.K. are beginning a human challenge trial that intentionally exposes volunteers to SARS-CoV-2 viruses to test candidate vaccines.
-

Myeloma Drug Shown to Treat Covid-19 Patients
Results from an early clinical trial show a drug designed to treat multiple myeloma also reduces viral loads and hospital stays of patients with Covid-19 infections.
-

ALS Drug Shown to Extend Patient Survival
Results of a clinical trial show a drug to treat amyotrophic lateral sclerosis, or ALS, extends patients’ survival by several months and slows decline of their functions.
-

Q3 Venture Funds Inch Up, Early-Stage Deals Drop
Venture capital funding rose in the third quarter of 2020, driven in large part by investments in already established companies rather than newer enterprises.